40.57

1.00% -0.3932

Atricure Inc (ATRC)

Overview News Price History Option Chain Financials Discussions Forecast

Atricure Inc stock is traded at $40.57, with a volume of 228.12K. It is down -1.00% in the last 24 hours and up +24.01% over the past month. AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.

Previous Close:

$40.96

Open:

$40.94

24h Volume:

228.12K

Relative Volume:

0.48

Market Cap:

$1.99B

Revenue:

$447.57M

Net Income/Loss:

$-38.92M

P/E Ratio:

-48.88

EPS:

-0.83

Net Cash Flow:

$-1.15M

1W Performance:

+1.71%

1M Performance:

+24.01%

6M Performance:

+99.36%

1Y Performance:

+22.84%

1-Day Range:

$40.32

$41.33

1-Week Range:

$38.90

$41.77

52-Week Range:

$18.94

$43.11

Atricure Inc Stock (ATRC) Company Profile

Name

Atricure Inc

Sector

Healthcare (1187)

Industry

Medical Instruments & Supplies (62)

Phone

513-755-4100

Address

7555 INNOVATION WAY, MASON, OH

Employee

1,200

Twitter

@AtriCure

Next Earnings Date

2024-10-29

Latest SEC Filings

ATRC's Discussions on Twitter

Compare ATRC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ATRC Atricure Inc	40.52	1.99B	447.57M	-38.92M	-1.15M	-0.83
ISRG Intuitive Surgical Inc	586.50	209.89B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	229.21	68.23B	20.18B	1.71B	3.07B	5.94
ALC Alcon Inc	90.16	45.33B	9.76B	1.16B	665.00M	2.34
RMD Resmed Inc	236.27	34.84B	4.93B	1.25B	1.38B	8.47
WST West Pharmaceutical Services Inc	321.21	23.97B	2.88B	499.60M	321.60M	6.74

Atricure Inc Stock (ATRC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Dec-17-24	Resumed	JP Morgan	Overweight
Apr-23-24	Upgrade	Oppenheimer	Perform → Outperform
Oct-23-23	Initiated	JMP Securities	Mkt Outperform
Sep-29-23	Initiated	UBS	Buy
Aug-05-21	Downgrade	Oppenheimer	Outperform → Perform
Dec-18-20	Reiterated	Needham	Buy
Nov-06-20	Reiterated	Needham	Buy
Apr-07-20	Initiated	Oppenheimer	Outperform
Feb-06-20	Initiated	BTIG Research	Buy
Jan-24-20	Reiterated	Needham	Buy
Aug-13-19	Downgrade	Northland Capital	Outperform → Market Perform
Apr-12-19	Initiated	JP Morgan	Overweight
Oct-04-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Needham	Buy
Aug-02-18	Reiterated	Stifel	Buy
Jun-18-18	Reiterated	Needham	Buy
Apr-27-18	Reiterated	Needham	Buy
Jan-16-18	Reiterated	Needham	Buy
Nov-02-17	Reiterated	Needham	Buy
Jul-28-17	Reiterated	Needham	Buy
May-30-17	Resumed	Piper Jaffray	Overweight
Jun-30-16	Resumed	JMP Securities	Mkt Outperform
Oct-28-15	Reiterated	Needham	Buy
Oct-06-15	Reiterated	Canaccord Genuity	Buy
Oct-06-15	Reiterated	Needham	Buy

View All

Atricure Inc Stock (ATRC) Latest News

Feb 06, 2025

Transcatheter Aortic Valve Replacement Market Future Business - openPR

Feb 06, 2025

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat

Feb 06, 2025

Feb 05, 2025

Calamos Advisors LLC Buys 24,147 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Feb 05, 2025

Feb 04, 2025

Atrial Fibrillation Systems Market Witness Booming Demand: - openPR

Feb 04, 2025

Feb 03, 2025

AtriCure (NASDAQ:ATRC) Stock Price Down 4.9%Should You Sell? - MarketBeat

Feb 03, 2025

AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of “Buy” by Brokerages - Defense World

Feb 03, 2025

Feb 01, 2025

AtriCure (NASDAQ:ATRC) Hits New 52-Week High Following Analyst Upgrade - MarketBeat

Jan 23, 2025

Jan 22, 2025

Needham reiterates Buy on AtriCure shares amid impressive growth and solid valuation - MSN

Jan 22, 2025

Revenues Tell The Story For AtriCure, Inc. (NASDAQ:ATRC) As Its Stock Soars 29% - Simply Wall St

Jan 22, 2025

AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at Needham & Company LLC - MarketBeat

Jan 22, 2025

AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results - Business Wire

Jan 22, 2025

Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) - Benzinga

Jan 22, 2025

Jan 21, 2025

Assenagon Asset Management S.A. Has $4.25 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World

Jan 21, 2025

Assenagon Asset Management S.A. Sells 90,029 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat

Jan 21, 2025

Jan 19, 2025

Atrial Fibrillation Surgery Market Trends & Insights 2025 -2033 - openPR

Jan 19, 2025

AtriCure stock soars to 52-week high, hits $39.08 - MSN

Jan 19, 2025

Orthofix Medical (NASDAQ:OFIX) vs. AtriCure (NASDAQ:ATRC) Head-To-Head Contrast - Defense World

Jan 19, 2025

Jan 18, 2025

AtriCure (NASDAQ:ATRC) Hits New 52-Week HighShould You Buy? - MarketBeat

Jan 18, 2025

Jan 17, 2025

AtriCure stock soars to 52-week high, hits $39.08 By Investing.com - Investing.com South Africa

Jan 17, 2025

AtriCure reports preliminary results for fourth quarter - MSN

Jan 17, 2025

Jan 15, 2025

AtriCure (ATRC) Stock Surges Over 5% Amid Market Activity - GuruFocus.com

Jan 15, 2025

AtriCure, Inc. (NASDAQ:ATRC) Shares Sold by JPMorgan Chase & Co. - MarketBeat

Jan 15, 2025

Jan 14, 2025

AtriCure projects growth, sets 2025 financial targets By Investing.com - Investing.com Australia

Jan 14, 2025

Jan 13, 2025

AtriCure projects growth, sets 2025 financial targets - Investing.com

Jan 13, 2025

Needham retains AtriCure stock buy rating after revenue beat By Investing.com - Investing.com Australia

Jan 13, 2025

AtriCure Q4 revenue prelims beat The Street - Mass Device

Jan 13, 2025

Long Term Trading Analysis for (ATRC) - Stock Traders Daily

Jan 13, 2025